Alnylam Pharmaceuticals
ALNY
ALNY
472 hedge funds and large institutions have $24B invested in Alnylam Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 170 increasing their positions, 169 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
2% less funds holding
Funds holding: 483 → 472 (-11)
15% less capital invested
Capital invested by funds: $28.3B → $24B (-$4.38B)
64% less funds holding in top 10
Funds holding in top 10: 14 → 5 (-9)
Holders
472
Holding in Top 10
5
Calls
$194M
Puts
$159M
Top Buyers
| 1 | +$322M | |
| 2 | +$102M | |
| 3 | +$93.7M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$93.1M |
| 5 |
Corient Private Wealth
Miami,
Florida
|
+$54.1M |
Top Sellers
| 1 | -$154M | |
| 2 | -$139M | |
| 3 | -$125M | |
| 4 |
Holocene Advisors
New York
|
-$116M |
| 5 |
1832 Asset Management
Toronto,
Ontario, Canada
|
-$73.8M |